Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study

INTRODUCTION: Palliative chemotherapy is the principal treatment of patients with advanced soft tissue sarcomas (STS); however prognosis is limited (median overall survival 12-19 months). In this setting, patient values and priorities are central to personalised treatment decisions. PATIENTS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Younger, E., Jones, R.L., den Hollander, D., Soomers, V.L.M.N., Desar, I.M.E., Benson, C., Young, R.J., Oosten, A.W., de Haan, J.J., Miah, A., Zaidi, S., Gelderblom, H., Steeghs, N., Husson, O., van der Graaf, W.T.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441156/
https://www.ncbi.nlm.nih.gov/pubmed/34509803
http://dx.doi.org/10.1016/j.esmoop.2021.100258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441156/
https://www.ncbi.nlm.nih.gov/pubmed/34509803
http://dx.doi.org/10.1016/j.esmoop.2021.100258

Ejemplares similares